Join us at the Cell & Gene Meeting on the Mesa!

Driving advanced therapies to the clinic

Join Integrated DNA Technologies (IDT) at the Cell & Gene Meeting on the Mesa. This premier partnering-focused event brings together leaders in cell and gene therapy to accelerate innovation and collaboration.

At IDT, we understand the challenges of therapeutic development. Our end-to-end CRISPR solutions from discovery to delivery are backed by expert regulatory support to help you move confidently toward clinical success.

Meet with our experts

We’re excited to meet you and discuss how IDT can support your cell and gene therapy development from research to clinical translation and beyond.

Reach out to us via the dedicated conference partnering app partneringONE® to schedule a meeting with our team or visit us at our tabletop in the MacArthur Building at the Arizona Biltmore Hotel.

Schedule a meeting

Not attending Meeting on the Mesa this year but want to schedule a meeting? Fill out this form and our team will reach out.

Our team

• Sandy Ottensmann, VP/GM Gene Writing & Editing
• Loren Schoch, Senior Director, Therapeutic Commercialization
• Nisha Bulsara, Clinical Development Leader
• Morgan Sturgeon, CRISPR Applications Development Manager
• Garrett Rettig, Senior Director of Product Development

Enabling real-world impact in CRISPR-based personalized therapies

The world’s first personalized CRISPR therapy was delivered to a newborn in just six months and was made possible with the contribution of coordinated expertise of IDT and Aldevron, setting a new standard for precision medicine.

Talk to our team to learn more and discover how IDT can support your CRISPR-based program.

Request a consultation

CRISPR Genome Editing Solutions

Therapeutic applications

• CRISPR CGMP gRNA manufacturing

  Engineering Run and CGMP guide RNA (gRNA) manufacturing services offering a streamlined and regulatory-compliant solution. Get a free consultation with one of our clinical development leaders.

• CGMP CRISPR nucleases

  Nucleases that provide an accelerated path to the clinic by offering the same product manufactured at research grade and full CGMP, supported by the quality documentation necessary for regulatory filings.

• CRISPR Off-target Analysis Service

  Leverage IDT’s deep expertise in CRISPR off-target analysis to deliver unparalleled off-target editing analytical services for your CRISPR projects from research to clinic, including IND support.

Research applications

Gene knock-out studies (non-homologous end joining, NHEJ)

• Alt-R™ CRISPR-Cas9 System
• Alt-R CRISPR-Cas12a (Cpf1) System

Gene knock-in studies (homology-directed repair, HDR)

• Alt-R HDR Design Tool*

*Available for wild type/HiFi Cas9 or nickase designs.